The effects of
3-O-methyl-D-glucose (3-OMG) on subcutaneously implanted murine radiation-induced
fibrosarcoma 1
tumor were examined with 2H, 13C, and 31P nuclear magnetic resonance (NMR) in situ. Using 31P NMR, changes in
tumor high-energy
phosphate metabolism were monitored for 2.5 h after i.p. administration of 3-OMG (8.1 g/kg
body weight);
tumor pH decreased by a mean maximum of 0.52 +/- 0.05 (SE) (n = 10), [PCr] decreased by 54%, [NTP] decreased by 35%, and [Pi] increased by 36%.
Tumor blood flow, as measured by 2H NMR monitoring of D2O washout kinetics, decreased by 40% at 1 h and by 47% at 2 h after 3-OMG injection (n = 4). This substantial
tumor acidification (pH decrease much greater than 0.1), expected to require a glycolytic substrate (Hwang et al.,
Cancer Res., 51: 3108-3118, 1991), is surprising in light of the previously documented metabolically inert nature of 3-OMG. In situ 13C NMR spectroscopy, following [6-13C]3-OMG i.p. injection, examined the possibility of the glycolytic metabolism of 3-OMG. However, only the C-6 resonance of 3-OMG was detected (n = 6); no resonances from [6-13C]3-OMG-6-
phosphate or [3-13C]
lactate were observed. These results confirmed that 3-OMG was not metabolized in radiation-induced
fibrosarcoma 1
tumor. At the completion of the in situ 13C NMR experiments,
tumors were freeze clamped, and
perchloric acid extraction was performed. High-resolution 1H NMR measurement of
lactate concentrations showed no statistically significant difference in control
tumor extracts (from mice not receiving i.p. injection; n = 5) and in
tumor extracts from mice administered i.p. [6-13C]3-OMG (n = 5), indicating that there was no significant increase in
lactate level in the
tumor extracts from mice administered i.p. 3-OMG due to increased plasma
glucose concentration. The results of these 1H and 13C NMR studies indicated that the radiation-induced
fibrosarcoma 1
tumor acidification caused by i.p. administration of 3-OMG was not due to a direct (3-OMG----lactate) or an indirect (systemic
glucose----
lactate) increase in
tumor lactic acid levels.